Neuropeptides and general neuronal marker in psoriasis - An immunohistochemical study

被引:56
作者
AlAbadie, MSK [1 ]
Senior, HJ [1 ]
Bleehen, SS [1 ]
Gawkrodger, DJ [1 ]
机构
[1] UNIV SHEFFIELD,ROYAL HALLAMSHIRE HOSP,DEPT MED,DERMATOL SECT,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND
关键词
D O I
10.1111/j.1365-2230.1995.tb01354.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Nerve fibres immunoreactive to antibodies to vasoactive intestinal polypeptide (VIP) and substance P (SP) were increased in lesional psoriatic skin when assessed semi-quantitatively. Biopsies from psoriatic plaques on the arm were studied in 13 patients and compared with biopsies from non-lesional areas (in three of the same psoriatic subjects) and from normal skin in seven non-psoriatic controls. Immunohistochemical methods were used on cryocut skin sections to demonstrate the neuropeptides SP, VIP, calcitonin gene-related peptide and neuropeptide Y, and the general neuronal marker protein gene product (PGP) 9.5. The immunofluorescence was examined by semiquantitative and, for PGP 9.5, by quantitative methods. VIP reactive nerve fibres were increased at areas of eccrine sweat glands throughout the dermis, at the dermo-epidermal junction, and in the epidermis, in psoriasis lesional skin. SP reactive nerve fibres were increased at the dermo-epidermal junction, where the nerves ran parallel with and perpendicularly through the junction. PGP 9.5 reactive nerve fibres showed an increase at the dermo-epidermal junction, in the papillary. dermis, and at the eccrine sweat glands in lesional psoriatic skin but not in non-lesional, or in control skin. These findings support the hypothesis that neuropeptides may be involved in the pathogenesis of psoriasis.
引用
收藏
页码:384 / 389
页数:6
相关论文
共 37 条
  • [1] NEUROPEPTIDES IN SKIN-DISEASE - INCREASED VIP IN ECZEMA AND PSORIASIS BUT NOT AXILLARY HYPERHIDROSIS
    ANAND, P
    SPRINGALL, DR
    BLANK, MA
    SELLU, D
    POLAK, JM
    BLOOM, SR
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1991, 124 (06) : 547 - 549
  • [2] T-CELL SUBPOPULATIONS IN THE BLOOD AND SKIN OF PATIENTS WITH PSORIASIS
    BAKER, BS
    SWAIN, AF
    VALDIMARSSON, H
    FRY, L
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1984, 110 (01) : 37 - 44
  • [3] EFFECTS OF TOPICALLY APPLIED CAPSAICIN ON MODERATE AND SEVERE PSORIASIS-VULGARIS
    BERNSTEIN, JE
    PARISH, LC
    RAPAPORT, M
    ROSENBAUM, MM
    ROENIGK, HH
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 15 (03) : 504 - 507
  • [4] BJORKLUND H, 1986, CELL TISSUE RES, V243, P51
  • [5] BLOOM S R, 1983, Clinical and Experimental Dermatology, V8, P3, DOI 10.1111/j.1365-2230.1983.tb01738.x
  • [7] BROWN J, 1989, J INVEST DERMATOL, V92, P407
  • [8] NEUROPEPTIDES AS GROWTH-FACTORS - POSSIBLE ROLES IN HUMAN-DISEASES
    DALSGAARD, CJ
    HULTGARDHNILSSON, A
    HAEGERSTRAND, A
    NILSSON, J
    [J]. REGULATORY PEPTIDES, 1989, 25 (01) : 1 - 9
  • [9] NEUROPEPTIDES IN PSORIASIS - AN IMMUNOCYTOCHEMICAL AND RADIOIMMUNOASSAY STUDY
    EEDY, DJ
    JOHNSTON, CF
    SHAW, C
    BUCHANAN, KD
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 96 (04) : 434 - 438
  • [10] STRESS AND PSORIASIS - PSYCHONEUROIMMUNOLOGIC MECHANISMS
    FARBER, EM
    REIN, G
    LANIGAN, SW
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1991, 30 (01) : 8 - 12